|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Amortization of intangibles | |||||
| Restructuring, goodwill impairment and asset related charges - net | |||||
| Equity in losses of nonconsolidated affiliates | |||||
| Sundry income (expense) - net | |||||
| Interest income | |||||
| Interest expense and amortization of debt discount | |||||
| Income (loss) before income taxes | |||||
| Provision (credit) for income taxes | |||||
| Net income (loss) | |||||
| Net income attributable to noncontrolling interests | |||||
| Net income (loss) available for The Dow Chemical Company common stockholder | |||||
| Earnings (loss) per common share - basic | |||||
| Earnings (loss) per common share - diluted | |||||
| Weighted-average common shares outstanding - basic | |||||
| Weighted-average common shares outstanding - diluted | |||||
Loading...